HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Expansion of ‘death with dignity’ laws raises practical, ethical questions for patients, providers
-
- ASH identifies three VTE, anticoagulation practices that should be avoided Stephan Moll, MD
- Co-deletion of 1p/19q associated with improved survival in glioma
- FOLFIRI plus panitumumab effective in metastatic colorectal cancer
- ACS: Cancer death rate continues its decline
- Registry offers insights into pediatric melanoma outcomes
- USPSTF issues finalized lung cancer screening recommendations
- Addition of tirapazamine to cisplatin chemoradiotherapy did not improve PFS in cervical cancer
- ETV6-NTRK3 rearrangement may indicate radiation-induced thyroid cancer
-
- Letrozole shows promise in advanced uterine leiomyosarcoma
- MET amplification, protein expression predicted shorter survival in gastric cancer
- Obesity associated with tumor indolence in renal cell carcinoma
- Tasquinimod improved PFS in metastatic castration-resistant prostate cancer
- Trastuzumab increased heart failure risk in older patients with breast cancer
- Induction, maintenance bortezomib improved survival in newly diagnosed multiple myeloma
- Variations between studies ‘not enough to question value of mammography’
- Adjuvant paclitaxel and trastuzumab extended DFS in HER-2–positive breast cancer
-
- Haploidentical HSCT graft manipulation prevented GVHD, improved survival in pediatric leukemia
- Lenalidomide plus dexamethasone prolonged PFS in multiple myeloma
- Obinutuzumab plus chlorambucil improved outcomes in untreated CLL
- Addition of Imprime PGG to chemotherapy improved outcomes in NSCLC
- Novel PD-1 antibody induced response in previously treated NSCLC
- NeoALTTO: pCR associated with EFS in HER-2–positive breast cancer